受强制性开放获取政策约束的文章 - Atsushi Suzuki, MD, PhD, ATSF了解详情
可在其他位置公开访问的文章：4 篇
Patient-centered outcomes research in interstitial lung disease: an official American Thoracic Society research statement
KI Aronson, SK Danoff, AM Russell, CJ Ryerson, A Suzuki, ...
American journal of respiratory and critical care medicine 204 (2), e3-e23, 2021
强制性开放获取政策： US National Institutes of Health, National Institute for Health Research, UK
Fibroblasts positive for meflin have anti-fibrotic properties in pulmonary fibrosis
Y Nakahara, N Hashimoto, K Sakamoto, A Enomoto, TS Adams, T Yokoi, ...
European Respiratory Journal 58 (6), 2021
强制性开放获取政策： US National Institutes of Health
Serum mitochondrial DNA predicts the risk of acute exacerbation and progression of idiopathic pulmonary fibrosis
K Sakamoto, T Furukawa, Y Yamano, K Kataoka, R Teramachi, A Walia, ...
European Respiratory Journal 57 (1), 2021
强制性开放获取政策： US National Institutes of Health
BMP3b is a novel antifibrotic molecule regulated by meflin in lung fibroblasts
A Suzuki, K Sakamoto, Y Nakahara, A Enomoto, J Hino, A Ando, M Inoue, ...
American Journal of Respiratory Cell and Molecular Biology 67 (4), 446-458, 2022
强制性开放获取政策： Japan Science and Technology Agency
出版信息和资助信息由计算机程序自动确定